For research use only. Not for therapeutic Use.
Pepinemab（Cat No.:I042192）is an investigational monoclonal antibody that targets the protein semaphorin 4D (Sema4D), which plays a role in immune system regulation and tumor progression. Sema4D is involved in immune cell signaling and has been implicated in inhibiting anti-tumor immunity. By blocking Sema4D, pepinemab aims to enhance immune responses against cancer cells and improve the effectiveness of cancer treatments. It is being studied in clinical trials for its potential to treat various cancers, including glioblastoma and other solid tumors, with the goal of improving patient outcomes through immune system modulation.
| CAS Number | 2097151-87-4 |
| Purity | ≥95% |
